IL13 and Alzheimer disease: In adults with moderate to severe AD, serum biomarker analysis further distinguishes between a low-inflammatory and a high-inflammatory group, with the latter showing elevated levels of TNFβ, monocyte chemoattractant protein 3 (MCP-3/CCL7), and IL-13 (139).